Since abundance of inositol was decreased and inositol-related signaling molecules were activated in IPF and/or ASS1-deficient lung fibroblast cells, we asked whether inositol supplementation could alter cellular metabolism and thereby disrupt inositol-driven signaling. The gene discussed is ASS1; the disease is idiopathic pulmonary fibrosis.